Nasdaq:US$13.33 (-0.09) | HKEX:HK$20.30 (-0.52) | AIM:£1.95 (-0.06)
搜索结果
上一篇文章   |   下一篇文章
公告及新闻稿, 其他业务 | 2014-04-17

Chi-Med and Sinopharm complete regulatory approval for the establishment of new China drug distribution and marketing Joint Venture